[
    "{\"step_by_step_thinking\": \"Based on the information provided in the documents, bleomycin is known to cause lung toxicity. Document [0] states that bleomycin lung injuries occur in 10% of patients and lead to severe interstitial pneumonia in 3% of patients. Document [2] mentions that pulmonary toxicity can occur with the use of bleomycin, especially when radiation therapy to the chest is also given. Document [5] describes bleomycin pulmonary toxicity rates of approximately 10% in patients taking bleomycin, with 14% of these cases proving fatal. Document [8] reports bleomycin lung damage in 18% of patients receiving ABVD for Hodgkin disease. Document [11] states that bleomycin pulmonary toxicity is a recognized adverse effect of the drug. Document [15] mentions that the most serious complication of bleomycin is pulmonary fibrosis and impaired lung function. Document [21] describes a case of fatal pulmonary fibrosis that developed after exposure to oxygen in a patient treated with bleomycin. Document [23] discusses the development of pulmonary fibrosis during treatment with bleomycin in children. Based on this information, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]